PATENT CLAIM ANALYSIS

Application Number: 15875757
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "093600"]

Abstract:
An oncolytic herpes simplex virus is disclosed for use in a method of treating cancer, the method comprising administering one or more doses of an oncolytic herpes simplex virus effective to induce a Th1 immune response in the subject, and optionally administering a therapeutically effective amount of an immune checkpoint inhibitor.

Claim (Index 13):
An oncolytic herpes simplex virus for use in a method according to any one of  claims 1  to  12 , wherein the subject is a human.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.42105
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15557783', '16068816', '16068823', '16068826', '14374619']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7557365765386489
- 35 USC 102 Novelty (BERT): 0.5434965865114689
- Combined Prediction Score: 0.7345125775359309
- Mean Citation Score: 355.01183000000015
- Max Citation Score: 397.81573
- Similarity Product: 299.20292140221886

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test